[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medicenna Therapeutics Corp (MDNA.TO)

Medicenna Therapeutics Corp (MDNA.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medicenna Therapeutics Corp 2 Bloor Street West Suite 903 Toronto ON M4W 3E2 CAN

https://www.medicenna.com P: 416-964-5442

Sector:

Medical

Description:

Medicenna Therapeutics Corp is the development and commercialization of IL-2, IL-4 and IL-13Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its platforms are Superkine, BISCUIT, TEMASK, Publications, and Scientific Publications.

Key Statistics

Overview:

Market Capitalization, $K 33,228
Shares Outstanding, K 92,300
% of Institutional Shareholders 0.43%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -18,409 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,234 K

Growth:

1-Year Return -58.14%
3-Year Return -35.71%
5-Year Return -87.28%
5-Year Revenue Growth 0.00%

Per-Share Information:

Next Earnings Date 02/12/25
Earnings Per Share ttm -0.22
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 46.67%
Dividend Payout Ratio 0.00%
Most Recent Split 1-14 on 03/03/17

MDNA.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -170.64%
Return-on-Assets % -99.95%
Profit Margin % 0.00%
Debt/Equity 0.02
Price/Sales N/A
Price/Book 13.39
Book Value/Share 0.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.